The browser doesnot support javascript
Print Plan Forms | Help

Medication Safety Alerts

CARBOplatin Injection 450 mg/45 mL 100 mL Multi-Dose Vials Voluntary Recall


On August 31, 2015, the United States Food and Drug Administration (FDA) issued a notice regarding a voluntary recall notice on CARBOplatin injection 450 mg/45 mL 100 mL multi-dose vials manufactured by Mylan Institutional. This recall was issued because particles were found during sample testing.

This may represent a potential health hazard or safety risk to plan members who may be using product affected by this recall.

This recall affects lot number 7801312 exp. 06/15. To see if you have affected product, please check the lot number. The lot number is located on the box the product came in and on the manufacturer’s label. If your product is not from lot number 7801312, it is not affected by this recall. If your product is from lot number 7801312, please return it to the pharmacy that filled your prescription.

Please call your doctor right away for advice if you may be using affected product or if you do not know if you used affected product or not. Your doctor is familiar with your medical history and can suggest the best treatment option for you. If you need a prescription for a different medicine, please call your doctor.

CVS/caremark Response:

Please note: This product is not carried by the CVS/caremark Mail Service Pharmacies.

If you are currently using CARBOplatin injection 450 mg/45 mL 100 mL multi-dose vials and have questions regarding this recall, please call your doctor or call Mylan Institutional toll-free at 1-800-796-9526, Monday through Friday, 8:00 am through 5:00 pm (ET). You may also call the FDA consumer inquiry line toll-free at 1‑888‑INFO-FDA (1‑888-463-6332) or visit their web site at

The CVS/caremark™ app lets you manage your prescription benefits on the go. Download it now:

CVS Health LogoCVS Pharmacy LogoCVS Minute Clinic LogoCVS Specialty LogoSilverscript LogoAccordant Logo

Copyright © 2018 CVS/caremark. All rights reserved| Terms and Conditions | Privacy Policy | Accessibility | Member Rights & Responsibilities